Hey shady, don't think anybody was really expecting outstanding results, though most of us would have wished for something a little more postive.
The market also perhaps seen it as ordinary too.
In the scheme of things am not sure if the 2% improvement is significant, better than going backwards for sure.
In regards to people seeing the result as disappointing that was not helped by the presention of the results at the webinar, I feel that this comes from the top down.
Do your think the webinar inspired confidence and enthusiasm?
Really hope sales take off (with clarification on immunotherapies division) so that the next webinar DOES inspire confidence and enthusiasm in the company's prospects.
Roadshow, page-51
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $10.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 911 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |